Compare PAHC & EFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PAHC | EFC |
|---|---|---|
| Founded | 1946 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.5B |
| IPO Year | 2014 | 2010 |
| Metric | PAHC | EFC |
|---|---|---|
| Price | $38.24 | $13.58 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | ★ $31.25 | $14.46 |
| AVG Volume (30 Days) | 298.0K | ★ 1.4M |
| Earning Date | 11-05-2025 | 11-05-2025 |
| Dividend Yield | 1.25% | ★ 11.49% |
| EPS Growth | ★ 288.74 | 1.22 |
| EPS | ★ 1.67 | 1.33 |
| Revenue | ★ $1,399,676,000.00 | $329,815,000.00 |
| Revenue This Year | $15.34 | N/A |
| Revenue Next Year | $3.28 | $8.81 |
| P/E Ratio | $23.08 | ★ $10.19 |
| Revenue Growth | ★ 33.72 | 13.84 |
| 52 Week Low | $16.16 | $11.12 |
| 52 Week High | $46.42 | $14.40 |
| Indicator | PAHC | EFC |
|---|---|---|
| Relative Strength Index (RSI) | 38.28 | 47.78 |
| Support Level | $38.27 | $13.59 |
| Resistance Level | $41.94 | $13.77 |
| Average True Range (ATR) | 1.91 | 0.18 |
| MACD | -0.57 | -0.02 |
| Stochastic Oscillator | 1.94 | 36.49 |
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
Ellington Financial Inc is a specialty finance company. Its primary investment objective is to generate attractive, risk-adjusted total returns for its shareholders by making investments. The company has two reportable segments; The Investment Portfolio Segment is focused on investing in a diverse array of financial assets, including residential and commercial mortgage loans, residential mortgage-backed securities, non-mortgage- and mortgage-related derivatives, debt and equity investments in loan origination companies, and other strategic investments, and The Longbridge Segment is focused on the origination and servicing of reverse mortgage loans. it acquires reverse mortgage loans both through its origination activities and through secondary market purchases.